The Meso-Rex bypass(MRB)is recognized as an effective treatment for portal hypertension secondary to extrahepatic portal vein occlusion(EHPVO)both in the pediatric and adult population,within or outside the context of...The Meso-Rex bypass(MRB)is recognized as an effective treatment for portal hypertension secondary to extrahepatic portal vein occlusion(EHPVO)both in the pediatric and adult population,within or outside the context of liver transplantation.It is the preferred surgical treatment in most centers because not only does it addresses the portal hypertension,but also restores physiologic portal hepatopetal flow.However,the Rex recess,the landmark for this technique,may not be safely accessible in some patients.We present a 22-year-old male who underwent living donor liver transplant(LDLT)for neonatal hepatitis.He presented with variceal bleeding due to EHPVO at 13 years after transplant.Various endoscopic,radiologic,and surgical interventions were employed to address the recurrent gastrointestinal bleeding,but results have been unsatisfactory.We performed a meso-intrahepatic portal vein bypass(MIPVB),an innovative alternative to the MRB,for this patient with extensive post-operative adhesions,perihilar collaterals,and cavernous transformation.MIPVB creation in patients where the Rex recess is inaccessible is technically challenging.But with a multidisciplinary team approach,meticulous preoperative planning,and close follow-up,the authors have demonstrated that it is a safe and feasible option for patients with late-onset EHPVO after liver transplantation.展开更多
文摘The Meso-Rex bypass(MRB)is recognized as an effective treatment for portal hypertension secondary to extrahepatic portal vein occlusion(EHPVO)both in the pediatric and adult population,within or outside the context of liver transplantation.It is the preferred surgical treatment in most centers because not only does it addresses the portal hypertension,but also restores physiologic portal hepatopetal flow.However,the Rex recess,the landmark for this technique,may not be safely accessible in some patients.We present a 22-year-old male who underwent living donor liver transplant(LDLT)for neonatal hepatitis.He presented with variceal bleeding due to EHPVO at 13 years after transplant.Various endoscopic,radiologic,and surgical interventions were employed to address the recurrent gastrointestinal bleeding,but results have been unsatisfactory.We performed a meso-intrahepatic portal vein bypass(MIPVB),an innovative alternative to the MRB,for this patient with extensive post-operative adhesions,perihilar collaterals,and cavernous transformation.MIPVB creation in patients where the Rex recess is inaccessible is technically challenging.But with a multidisciplinary team approach,meticulous preoperative planning,and close follow-up,the authors have demonstrated that it is a safe and feasible option for patients with late-onset EHPVO after liver transplantation.
